| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF02788530 |
| P698 | PubMed publication ID | 7622936 |
| P2093 | author name string | M K Herrington | |
| T E Adrian | |||
| P2860 | cites work | Effects of a Cholecystokinin Receptor Antagonist on Rat Exocrine Pancreatic Response to Raw Soya Flour | Q68312744 |
| Specific binding of cholecystokinin, estradiol and somatostatin to human pancreatic cancer xenografts | Q68325510 | ||
| Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990 | Q68581002 | ||
| Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters | Q68640947 | ||
| Effects of cerulein on the normal pancreas and on experimental pancreatic carcinoma in the Syrian golden hamster | Q68992634 | ||
| Effect of a trypsin inhibitor from soybeans (Bowman-Birk) on the secretory activity of the human pancreas | Q69012726 | ||
| Effect of bombesin and caerulein on early stages of carcinogenesis induced by azaserine in the rat pancreas | Q69017395 | ||
| Response to exogenous cholecystokinin of six human gastrointestinal cancers xenografted in nude mice | Q69059131 | ||
| The effect of gastrointestinal hormones on the incorporation of tritiated thymidine in the pancreatic adenocarcinoma cell line (WD PaCa) | Q69408230 | ||
| Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas | Q69586028 | ||
| Cholecystokinin and gastrin peptides stimulate ODC activity in a rat pancreatic cell line | Q69607273 | ||
| Regulation of growth and differentiation in pancreatic cancer. Bethesda, Maryland, September 19 and 20, 1988 | Q69670696 | ||
| Glycine-extended processing intermediates of gastrin and cholecystokinin in human plasma | Q69750070 | ||
| Inhibition of growth of a transplanted rat pancreatic acinar carcinoma with CCK-8 | Q70628201 | ||
| The effects of long-term feeding of soya flour on the rat pancreas | Q70654885 | ||
| Architecture of human pancreas: implications for early changes in pancreatic disease | Q71738302 | ||
| Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas | Q72126227 | ||
| Overexpression of messenger RNA for cholecystokinin-A receptor and novel expression of messenger RNA for gastrin (cholecystokinin-B) receptor in azaserine-induced rat pancreatic carcinoma | Q72560503 | ||
| Inhibition of intraduodenal trypsin does not stimulate exocrine pancreatic secretion in man | Q72705515 | ||
| Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines | Q72764892 | ||
| Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors | Q72896670 | ||
| Differential expression of A- and B-subtypes of cholecystokinin/gastrin receptors in the developing calf pancreas | Q72911598 | ||
| Inhibitory effects of a cholecystokinin antagonist, loxiglumide (CR-1505), on the growth of freshly separated and xenografted human pancreatic cancer | Q72966853 | ||
| The effects of soy flour and N-nitrosobis (2-oxopropyl) amine on the pancreas of the hamster | Q93609605 | ||
| Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor | Q24310716 | ||
| A new approach for induction of pancreatic neoplasms | Q28338911 | ||
| Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists | Q28340018 | ||
| Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression | Q28572382 | ||
| Stimulatory effect of monitor peptide and human pancreatic secretory trypsin inhibitor on pancreatic secretion and cholecystokinin release in conscious rats | Q28581824 | ||
| ras oncogenes in human cancer: a review | Q29547769 | ||
| Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat. | Q34191552 | ||
| Biology of pancreatic cancer | Q34394264 | ||
| Longterm pancreaticobiliary diversion stimulates hyperplastic and adenomatous nodules in the rat pancreas: a new model for spontaneous tumour formation | Q34533151 | ||
| Fate of pancreatic nodules induced by raw soya flour in rats | Q34533168 | ||
| A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus | Q34564624 | ||
| Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist | Q35615494 | ||
| Pancreatic cancer: the role of cholecystokinin? | Q35645684 | ||
| Derivation of ductlike cell lines from a transplantable acinar cell carcinoma of the rat pancreas | Q35832984 | ||
| Hormonal control of pancreatic growth | Q35899707 | ||
| Experimental pancreatic hyperplasia and neoplasia: effects of dietary and surgical manipulation | Q35976722 | ||
| Potentiation of azaserine by cholestyramine in the rat | Q36029262 | ||
| Cholecystokinin antagonists | Q37774148 | ||
| Role of bile acids in the control of pancreatic secretion and CCK release | Q37830501 | ||
| Effects of pancreaticobiliary diversion and gastric fundectomy on azaserine-induced pancreatic carcinogenesis in the rat. | Q53480535 | ||
| Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas | Q53489462 | ||
| Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters | Q53495161 | ||
| Inhibitory effects of soybean trypsin inhibitor during initiation and promotion phases of N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis. | Q53501723 | ||
| Effect of cholecystokinin on pancreatic carcinogenesis in the hamster model. | Q53523032 | ||
| The effect of the long-term feeding of raw soy flour on the pancreas of the mouse and hamster. | Q53538855 | ||
| Studies of the effect of cerulein administration on experimental pancreatic carcinogenesis. | Q53555239 | ||
| Cholecystokinin inhibits pancreatic and hepatic carcinogenesis. | Q53562019 | ||
| Phenylethylamide derivatives of the C-terminal tetrapeptide of gastrin | Q58101687 | ||
| Lymph node involvement in carcinoma of the head of the pancreas area | Q67316105 | ||
| Role of cholecystokinin in induction and maintenance of dietary protein-stimulated pancreatic growth | Q67534357 | ||
| Trophic effects of unsulfated cholecystokinin on mouse pancreas and human pancreatic cancer | Q67541967 | ||
| Reduced cholecystokinin mediates the inhibition of pancreatic growth induced by bile salts | Q67664818 | ||
| Essential Role of Cholecystokinin in Pancreatic Regeneration After 60% Distal Resection in Rats | Q67698089 | ||
| Effects of UFT and loxiglumide (CR1505) on liver metastasis of human pancreatic cancer cell line, KP-1 N in nude mice | Q68016639 | ||
| Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas | Q68051353 | ||
| Endogenous cholecystokinin release responsible for pancreatic growth observed after pancreatic juice diversion | Q68063136 | ||
| Involvement of endogenous cholecystokinin in pancreatic regeneration after cerulein-induced acute pancreatitis | Q68137794 | ||
| Classification of pancreatic cancer (nonendocrine) | Q37969146 | ||
| Cholecystokinin and gastrointestinal cancer | Q38031478 | ||
| Effects of gastrointestinal peptides on gastrointestinal cancer growth | Q38757563 | ||
| Cholecystokinin receptor antagonists | Q39536067 | ||
| Role of cholecystokinin in pancreatic adaptation to massive enterectomy | Q39580584 | ||
| Role of gastrin and cholecystokinin in tumours of the gastrointestinal tract | Q39635742 | ||
| Interface between adaptive and neoplastic growth in the pancreas | Q39685995 | ||
| Studies of pancreatic carcinogenesis in different animal models | Q40187297 | ||
| The tumor biology of gastrin and cholecystokinin | Q40675133 | ||
| Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin | Q40682809 | ||
| Hormonal therapy of pancreatic carcinoma. Rationale and perspectives. | Q40712629 | ||
| Effect of chronic pentagastrin, cholecystokinin, and secretin on pancreas of rats | Q40864402 | ||
| A cholecystokinin releasing peptide mediates feedback regulation of pancreatic secretion | Q41255517 | ||
| Growth-promoting effects of glycine-extended progastrin | Q41454851 | ||
| Cholecystokinin receptors and PANC-1 human pancreatic cancer cells | Q41544608 | ||
| Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization | Q41588922 | ||
| Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cells | Q41596812 | ||
| Growth inhibition of human pancreatic cancer cells by cholecystokinin receptor antagonist in tissue culture and in nude mice | Q41641498 | ||
| CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium | Q41694806 | ||
| Functional and molecular characterization of CCK receptors in the rat pancreatic acinar cell line AR 4-2J. | Q41698272 | ||
| Inhibition of cell proliferation by the cholecystokinin antagonist L-364,718. | Q41702365 | ||
| Lorglumide and loxiglumide inhibit gastrin-stimulated DNA synthesis in a rat tumoral acinar pancreatic cell line (AR42J). | Q41721482 | ||
| Effects of a high-fat diet and L364,718 on growth of human pancreas cancer | Q41731843 | ||
| Growth effects of regulatory peptides on human pancreatic cancer lines PANC-1 and MIA PaCa-2. | Q41732306 | ||
| Gastrin modulates growth of a rat acinar pancreatic cell line: receptor analysis and signal transduction | Q41751417 | ||
| Establishment of a New Human Pancreatic Adenocarcinoma Cell Line, MDAPanc-3 | Q41757507 | ||
| Characterisation of gastrin receptors on a rat pancreatic acinar cell line (AR42J). A possible model for studying gastrin mediated cell growth and proliferation | Q41781940 | ||
| Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion | Q41827161 | ||
| Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude mice | Q41936517 | ||
| Pancreatic cancer: the greatest oncological challenge | Q41941898 | ||
| Enhancing effect of partial gastrectomy on pancreatic carcinogenesis | Q42023653 | ||
| Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist | Q42219772 | ||
| Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease | Q42249735 | ||
| Pharmacological profile of FK480, a novel cholecystokinin type-A receptor antagonist: comparison to loxiglumide. | Q42275045 | ||
| Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats | Q42371569 | ||
| Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model | Q42374570 | ||
| Pancreatobiliary diversion enhances experimental pancreatic carcinogenesis | Q42383773 | ||
| Inhibitory effects of the gastrin receptor antagonist (L-365,260) on gastrointestinal tumor cells | Q42471834 | ||
| Glucocorticoids increase cholecystokinin receptors and amylase secretion in pancreatic acinar AR42J cells. | Q42486585 | ||
| Characterization of gastrin receptors on guinea pig pancreatic acini | Q42488592 | ||
| Activation of c-K-ras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats | Q43413137 | ||
| Cancer statistics, 1990. | Q43526438 | ||
| Studies on human pancreatic acini: action of secretagogues on amylase release and cellular cyclic AMP accumulation | Q44021306 | ||
| Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas | Q44117057 | ||
| Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals | Q44710230 | ||
| Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats | Q44851659 | ||
| Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide | Q45254181 | ||
| Receptors for cholecystokinin and gastrin peptides display specific binding properties and are structurally different in guinea-pig and dog pancreas. | Q46211148 | ||
| Effect of CCK receptor antagonist on growth of pancreatic adenocarcinoma | Q46507630 | ||
| Gastrointestinal hormones and gastrointestinal and pancreatic carcinomas | Q46541960 | ||
| New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity | Q46776429 | ||
| Two brain cholecystokinin receptors: implications for behavioral actions | Q48417682 | ||
| A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity | Q48843929 | ||
| Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster | Q51600980 | ||
| Effects of pancreastatin (24-49) on growth of normal pancreas and pancreatic cancer. | Q51609438 | ||
| A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer | Q53027312 | ||
| Effects of raw soya diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster. | Q53471081 | ||
| Novel expression of gastrin (CCK-B) receptors in pancreatic carcinomas and dysplastic pancreas from transgenic mice. | Q53474901 | ||
| Temporal expression of the gastrin (CCK-B) receptor during azaserine-induced pancreatic carcinogenesis. | Q53478491 | ||
| P433 | issue | 2 | |
| P921 | main subject | cholecystokinin | Q60315441 |
| P304 | page(s) | 121-138 | |
| P577 | publication date | 1995-04-01 | |
| P1433 | published in | International Journal of Pancreatology | Q27711541 |
| P1476 | title | On the role of cholecystokinin in pancreatic cancer. | |
| P478 | volume | 17 |
Search more.